Comparison of Sensititre YeastOne® with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus

Diagnostic Microbiology and Infectious Disease

Volumn 56, Issue 1, 2006, Pages 53-55

  Guinea, Jesús ^a   Peláez, Teresa ^a   Alcalá, Luis ^a   Bouza, Emilio ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

A. fumigatus; Amphotericin B; Itraconazole; NCCLS M38 A; Sensititre YeastOne; Voriconazole

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ITRACONAZOLE; VORICONAZOLE;

ANALYTIC METHOD; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; DIAGNOSTIC KIT; DRUG SENSITIVITY; FUNGUS ISOLATION; IN VITRO STUDY; INTERMETHOD COMPARISON; NCCLS M38 A MICRODILUTION METHOD; NONHUMAN; PRIORITY JOURNAL; SENSITITRE YEASTONE MICRODILUTION METHOD;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; PYRIMIDINES; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TRIAZOLES;

EID: 33747796604     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2006.03.004     Document Type: Article

References (12)

1. Bouza E., Guinea J., et al. Workload due to Aspergillus fumigatus and significance of the organism in the microbiology laboratory of a general hospital. J. Clin. Oncol. 43 (2005) 2075-2079
2. Castro C., Serrano M.C., et al. Comparison of the Sensititre YeastOne colorimetric antifungal panel with a modified NCCLS M38-A method to determine the activity of voriconazole against clinical isolates of Aspergillus spp. J. Clin. Oncol. 42 (2004) 4358-4360
3. Denning D.W. Invasive aspergillosis. Clin. Infect. Dis. 26 (1998) 781-805
4. Denning D.W., Radford S.A., et al. Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection. J. Antimicrob. Chemother. 40 (1997) 401-414
5. Denning D.W., Venkateswarlu K., et al. Itraconazole resistance in Aspergillus fumigatus. Antimicrob. Agents Chemother. 41 (1997) 1364-1368
6. Espinel-Ingroff A., Bartlett M., et al. Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation. National Committee for Clinical Laboratory Standards. Antimicrob. Agents Chemother. 45 (2001) 1828-1835
7. Groll A.H., Shah P.M., et al. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J. Infect. 33 (1996) 23-32
8. Guinea J., Pelaez T., et al. Antifungal susceptibility of 596 A. fumigatus strains isolated from outdoor air, hospital air and clinical samples: analysis by site of isolation. Antimicrob. Agents Chemother. 49 (2005) 3495-3497
9. Lass-Florl C., Kofler G., et al. In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis. J. Antimicrob. Chemother. 42 (1998) 497-502
10. Martin-Mazuelos E., Peman J., et al. Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp. J. Antimicrob. Chemother. 52 (2003) 365-370
11. Meletiadis J., Mouton J.W., et al. Comparison of the Etest and the sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus species. J. Clin. Oncol. 40 (2002) 2876-2885
12. NCCLS. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved Standard. NCCLS document M38-A. NCCLS 18 (2002) 1-29